SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-19-306309
Filing Date
2019-12-04
Accepted
2019-12-04 17:18:12
Documents
10

Document Format Files

Seq Description Document Type Size
1 424B5 d842091d424b5.htm 424B5 940166
2 GRAPHIC g842091d0001_818392.jpg GRAPHIC 49429
3 GRAPHIC g842091d0001_842091.jpg GRAPHIC 20259
4 GRAPHIC g842091d0002_818392.jpg GRAPHIC 48329
5 GRAPHIC g842091d0002_842091.jpg GRAPHIC 35122
6 GRAPHIC g842091d0003_818392.jpg GRAPHIC 49383
7 GRAPHIC g842091g02q20.jpg GRAPHIC 33289
8 GRAPHIC g842091g02t12.jpg GRAPHIC 113383
9 GRAPHIC g842091g05b00.jpg GRAPHIC 131603
10 GRAPHIC g842091s0001_842091.jpg GRAPHIC 37198
  Complete submission text file 0001193125-19-306309.txt   1656163
Mailing Address 83 CLEMENCEAU AVENUE #12-03 UE SQUARE SINGAPORE U0 239920
Business Address 83 CLEMENCEAU AVENUE #12-03 UE SQUARE SINGAPORE U0 239920 65 6222 4235
ASLAN Pharmaceuticals Ltd (Filer) CIK: 0001722926 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-234405 | Film No.: 191268856
SIC: 2834 Pharmaceutical Preparations